Literature DB >> 7204989

Cryopreservation of human lymphocytes for sequential testing of immune competence.

S A Birkeland.   

Abstract

Frozen stored lymphocytes are frequently used for sequential testing of immunological function in patients. The reliability of this system was investigated. By varying combinations of factors, it has been shown that lymphocyte samples, taken at different times and subsequently tested as a batch, give the most consistent results, the means of the various immune parameters measured on different sampling days in normal persons lying on straight lines parallel with the time axis. It is also shown that storage at -90 degrees C is equivalent to storage at -196.5% C.

Entities:  

Mesh:

Year:  1980        PMID: 7204989     DOI: 10.1016/0022-1759(80)90150-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Interferon (type-alpha and gamma) production by fresh and cryopreserved human mononuclear cells. Brief report.

Authors:  A C Banerjea; N Kedarnath; M M Gore; C Dayaraj; A V Jamkar; S N Ghosh
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

2.  Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid.

Authors:  M J Welch; S Fong; J Vaughan; D Carson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

3.  Loss of T cell responses following long-term cryopreservation.

Authors:  Rachel E Owen; Elizabeth Sinclair; Brinda Emu; John W Heitman; Dale F Hirschkorn; C Lorrie Epling; Qi Xuan Tan; Brian Custer; Jeffery M Harris; Mark A Jacobson; Joseph M McCune; Jeffery N Martin; Frederick M Hecht; Steven G Deeks; Philip J Norris
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

4.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Authors:  E M Carvalho; O Bacellar; A Barral; R Badaro; W D Johnson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.